| Q44275741 | A University of California State-supported AIDS research award program--a unique state and university partnership in AIDS research |
| Q33613718 | A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter |
| Q35862080 | A critical role for the TAR element in promoting efficient human immunodeficiency virus type 1 reverse transcription |
| Q40115668 | A discrete cis element in the human immunodeficiency virus long terminal repeat mediates synergistic trans activation by cytomegalovirus immediate-early proteins |
| Q39872176 | A human chromosome 12-associated 83-kilodalton cellular protein specifically binds to the loop region of human immunodeficiency virus type 1 trans-activation response element RNA. |
| Q35488480 | A mutant tat protein inhibits HIV-1 reverse transcription by targeting the reverse transcription complex. |
| Q40505766 | A new cAMP response element in the transcribed region of the human c-fos gene |
| Q39717672 | A small circular TAR RNA decoy specifically inhibits Tat-activated HIV-1 transcription |
| Q33662926 | A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat |
| Q33787595 | Activity of synthetic tat peptides in human immunodeficiency virus type 1 long terminal repeat-promoted transcription in a cell-free system |
| Q41079020 | Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro. |
| Q36828521 | Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation |
| Q36696760 | Bovine immunodeficiency-like virus encodes factors which trans activate the long terminal repeat |
| Q41935503 | CTGC motifs within the HIV core promoter specify Tat-responsive pre-initiation complexes |
| Q33795939 | Cell cycle-regulated transcription by the human immunodeficiency virus type 1 Tat transactivator |
| Q28342742 | Cell type-specific anti-human immunodeficiency virus type 1 activity of the transactivation inhibitor Ro5-3335 |
| Q36801667 | Characterization of murine monoclonal antibodies to the tat protein from human immunodeficiency virus type 1 |
| Q41576182 | Characterization of the inducer of short transcripts, a human immunodeficiency virus type 1 transcriptional element that activates the synthesis of short RNAs. |
| Q40064606 | Chicken ovalbumin upstream promoter transcription factor binds to a negative regulatory region in the human immunodeficiency virus type 1 long terminal repeat. |
| Q37251783 | Circular dichroism and molecular modeling yield a structure for the complex of human immunodeficiency virus type 1 trans-activation response RNA and the binding region of Tat, the trans-acting transcriptional activator |
| Q24317451 | Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs |
| Q24294198 | Cloning and chromosomal mapping of a human immunodeficiency virus 1 "TATA" element modulatory factor |
| Q24308836 | Cloning of a cellular factor, interleukin binding factor, that binds to NFAT-like motifs in the human immunodeficiency virus long terminal repeat |
| Q43564279 | Comparative Analysis of Tat-Dependent and Tat-Deficient Natural Lentiviruses |
| Q40454547 | Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape. |
| Q36797366 | Contribution of NF-kappa B and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types |
| Q37972643 | Control of HIV latency by epigenetic and non-epigenetic mechanisms |
| Q36798014 | Critical chemical features in trans-acting-responsive RNA are required for interaction with human immunodeficiency virus type 1 Tat protein |
| Q36807977 | Cytomegalovirus activates transcription directed by the long terminal repeat of human immunodeficiency virus type 1. |
| Q35792991 | Detailed mutational analysis of TAR RNA: critical spacing between the bulge and loop recognition domains |
| Q40041542 | Differential growth kinetics are exhibited by human immunodeficiency virus type 1 TAR mutants |
| Q40037851 | Differential role of long terminal repeat control elements for the regulation of basal and Tat-mediated transcription of the human immunodeficiency virus in stimulated and unstimulated primary human macrophages |
| Q53692218 | Distinctive variation in the U3R region of the 5' Long Terminal Repeat from diverse HIV-1 strains. |
| Q35040154 | Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription |
| Q40041905 | Effects of human chromosome 12 on interactions between Tat and TAR of human immunodeficiency virus type 1. |
| Q36687077 | Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines |
| Q35835407 | Efficient trans-activation by the HIV-2 Tat protein requires a duplicated TAR RNA structure |
| Q38358545 | Efficient transcription and replication of simian immunodeficiency virus in the absence of NF-kappaB and Sp1 binding elements |
| Q38335483 | Enhancement of RNA polymerase II initiation complexes by a novel DNA control domain downstream from the cap site of the cytomegalovirus major immediate-early promoter |
| Q36793376 | Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs |
| Q37633114 | Evolution of a disrupted TAR RNA hairpin structure in the HIV-1 virus. |
| Q33930854 | Functional comparison of the basic domains of the Tat proteins of human immunodeficiency virus types 1 and 2 in trans activation |
| Q24655684 | Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat |
| Q37460075 | Genotypic and phenotypic heterogeneity in the U3R region of HIV type 1 subtype C. |
| Q33271774 | Glucocorticoid receptor-binding site in the human immunodeficiency virus long terminal repeat |
| Q28475647 | HIV promoter integration site primarily modulates transcriptional burst size rather than frequency |
| Q35937536 | HIV-1 Tat protein promotes formation of more-processive elongation complexes |
| Q41234955 | HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure |
| Q24564505 | Herpes simplex virus latency-associated transcript is a stable intron |
| Q35928622 | Heterologous basic domain substitutions in the HIV-1 Tat protein reveal an arginine-rich motif required for transactivation |
| Q37086989 | Host Double Strand Break Repair Generates HIV-1 Strains Resistant to CRISPR/Cas9. |
| Q40066542 | Human chromosome 12 is required for optimal interactions between Tat and TAR of human immunodeficiency virus type 1 in rodent cells |
| Q36330062 | Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradication |
| Q34303073 | Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro |
| Q36798955 | Human immunodeficiency virus Tat transactivation: induction of a tissue-specific enhancer in a nonpermissive cell line |
| Q38293063 | Human immunodeficiency virus type 1 TAR element revertant viruses define RNA structures required for efficient viral gene expression and replication |
| Q36640831 | Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms |
| Q37633631 | Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity. |
| Q34043082 | Human transcription factor USF stimulates transcription through the initiator elements of the HIV-1 and the Ad-ML promoters |
| Q39506084 | Human-Phosphate-Binding-Protein inhibits HIV-1 gene transcription and replication |
| Q33575002 | Identification and characterization of a HeLa nuclear protein that specifically binds to the trans-activation-response (TAR) element of human immunodeficiency virus |
| Q40066797 | Identification of lentivirus tat functional domains through generation of equine infectious anemia virus/human immunodeficiency virus type 1 tat gene chimeras |
| Q38317787 | Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells |
| Q35792284 | Identification of transcriptional suppressor proteins that bind to the negative regulatory element of the human immunodeficiency virus type 1 |
| Q91644479 | Idiosyncrasies of Viral Noncoding RNAs Provide Insights into Host Cell Biology |
| Q36148507 | Impact of Tat Genetic Variation on HIV-1 Disease |
| Q38604868 | In silico Analyses of Subtype Specific HIV-1 Tat-TAR RNA Interaction Reveals the Structural Determinants for Viral Activity |
| Q24655901 | In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor |
| Q36654807 | Increased spacing between Sp1 and TATAA renders human immunodeficiency virus type 1 replication defective: implication for Tat function. |
| Q41677385 | Inhibition of human immunodeficiency virus replication in a human T cell line by antisense RNA expressed in the cell |
| Q24671522 | Interactions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivator |
| Q40108183 | Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of west-central African origin |
| Q40045425 | Juxtaposition between activation and basic domains of human immunodeficiency virus type 1 Tat is required for optimal interactions between Tat and TAR. |
| Q33815611 | Mechanisms of HIV Transcriptional Regulation by Drugs of Abuse |
| Q33864438 | Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage |
| Q36831514 | Multiple transcriptional regulatory domains in the human immunodeficiency virus type 1 long terminal repeat are involved in basal and E1A/E1B-induced promoter activity |
| Q36715276 | Muscle-specific activity of the skeletal troponin I promoter requires interaction between upstream regulatory sequences and elements contained within the first transcribed exon |
| Q36804564 | Mutational analysis of the conserved cysteine-rich region of the human immunodeficiency virus type 1 Tat protein |
| Q36700611 | Mutational analysis of the equine infectious anemia virus Tat-responsive element |
| Q36724734 | Mutations generated in human immunodeficiency virus type 1 long terminal repeat during vertical transmission correlate with viral gene expression |
| Q24682057 | Mutations in the carboxy-terminal domain of TBP affect the synthesis of human immunodeficiency virus type 1 full-length and short transcripts similarly |
| Q55482466 | NF-κB site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells |
| Q37177251 | Negative Feedback Regulation of HIV-1 by Gene Editing Strategy |
| Q39719048 | Optimal Tat-mediated activation of the HIV-1 LTR promoter requires a full-length TAR RNA hairpin |
| Q28480941 | Parental LTRs are important in a construct of a stable and efficient replication-competent infectious molecular clone of HIV-1 CRF08_BC |
| Q35890968 | Placental trophoblasts resist infection by multiple human immunodeficiency virus (HIV) type 1 variants even with cytomegalovirus coinfection but support HIV replication after provirus transfection |
| Q40066451 | Premature termination and processing of human immunodeficiency virus type 1-promoted transcripts |
| Q40308906 | Probing protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1 by in vivo footprinting |
| Q39877972 | RNA-targeted activators, but not DNA-targeted activators, repress the synthesis of short transcripts at the human immunodeficiency virus type 1 long terminal repeat. |
| Q34063531 | Raf-1 is required for T cell IL2 production. |
| Q24651506 | Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors |
| Q36629200 | Rev-dependent indicator T cell line |
| Q24324023 | Role of flanking E box motifs in human immunodeficiency virus type 1 TATA element function |
| Q36642257 | Role of tumor necrosis factor alpha in activation and replication of the tat-defective human immunodeficiency virus type 1. |
| Q36633683 | Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription f |
| Q39581570 | Sequences just upstream of the simian immunodeficiency virus core enhancer allow efficient replication in the absence of NF-kappaB and Sp1 binding elements |
| Q42457052 | Sequences within the R region of the long terminal repeat activate basal transcription from the HIV-1 promoter. |
| Q39872155 | Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat |
| Q24561778 | Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein |
| Q28305648 | Spatial association of HIV-1 tat protein and the nucleolar transport protein B23 in stably transfected Jurkat T-cells |
| Q24564875 | Specific binding of RNA polymerase II to the human immunodeficiency virus trans-activating region RNA is regulated by cellular cofactors and Tat |
| Q34284937 | Specific binding of a HeLa cell nuclear protein to RNA sequences in the human immunodeficiency virus transactivating region |
| Q42468627 | Stimulation of Tat-associated kinase-independent transcriptional elongation from the human immunodeficiency virus type-1 long terminal repeat by a cellular enhancer |
| Q35247429 | Strong epistatic selection on the RNA secondary structure of HIV |
| Q36796119 | Structural analysis of wild-type and mutant human immunodeficiency virus type 1 Tat proteins |
| Q36802812 | Structural requirements for trans activation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by tat: importance of base pairing, loop sequence, and bulges in the tat-responsive sequence. |
| Q24644981 | Synergistic activation of the human immunodeficiency virus type 1 promoter by the viral Tat protein and cellular transcription factor Sp1 |
| Q24650854 | T helper cell activation and human retroviral pathogenesis |
| Q42848859 | TAR RNA decoys inhibit tat-activated HIV-1 transcription after preinitiation complex formation |
| Q41238682 | TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes |
| Q40046655 | TAR loop-dependent human immunodeficiency virus trans activation requires factors encoded on human chromosome 12. |
| Q36639281 | TAR-independent transactivation of the murine cytomegalovirus major immediate-early promoter by the Tat protein |
| Q24815711 | Tat gets the "green" light on transcription initiation |
| Q38347693 | Tat is required for efficient HIV-1 reverse transcription |
| Q33886447 | Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded-RNA-activated protein kinase |
| Q35885321 | The Chinese herb-derived Sparstolonin B suppresses HIV-1 transcription |
| Q40731101 | The HIV-1 Tat Protein Is Monomethylated at Lysine 71 by the Lysine Methyltransferase KMT7 |
| Q34823344 | The activation region of the Tat protein of human immunodeficiency virus type-1 functions in yeast |
| Q24312742 | The cellular factor TRP-185 regulates RNA polymerase II binding to HIV-1 TAR RNA |
| Q36906001 | The effects of cocaine on HIV transcription |
| Q36649447 | The full-length Tat protein is required for TAR-independent, posttranscriptional trans activation of human immunodeficiency virus type 1 env gene expression. |
| Q33805882 | The human immunodeficiency virus type 1 TAR RNA upper stem-loop plays distinct roles in reverse transcription and RNA packaging |
| Q36632734 | The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure. |
| Q37548928 | The number of positively charged amino acids in the basic domain of Tat is critical for trans-activation and complex formation with TAR RNA |
| Q24319734 | The type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genes |
| Q24533266 | Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages |
| Q33938049 | Transcription factor AP-2 activates gene expression of HTLV-I |
| Q35845347 | Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. |
| Q33630942 | Transcriptional activation by Sp1 as directed through TATA or initiator: specific requirement for mammalian transcription factor IID |
| Q36656119 | Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16 |
| Q34030804 | Transcriptional and posttranscriptional regulation of HIV-1 gene expression |
| Q36797785 | Transcriptional elongation by purified RNA polymerase II is blocked at the trans-activation-responsive region of human immunodeficiency virus type 1 in vitro |
| Q39870080 | Transcriptional trans activation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors. |
| Q38342881 | Transfer of Tat and release of TAR RNA during the activation of the human immunodeficiency virus type-1 transcription elongation complex |
| Q38330641 | Unusual structure of the human immunodeficiency virus type 1 trans-activation response element |
| Q36630786 | Upstream U3 sequences in simian immunodeficiency virus are selectively deleted in vivo in the absence of an intact nef gene. |
| Q36832567 | trans activation of human immunodeficiency virus type 1 is sequence specific for both the single-stranded bulge and loop of the trans-acting-responsive hairpin: a quantitative analysis. |